{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T05:22:58Z","timestamp":1792905778703,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Leukemia Research"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.leukres.2022.107001","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T20:10:47Z","timestamp":1671567047000},"page":"107001","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort"],"prefix":"10.1016","volume":"125","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5183-2657","authenticated-orcid":false,"given":"Naveen","family":"Premnath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga K.","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Ikpefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohak","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gurbakhash","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Praveen Ramakrishnan","family":"Geethakumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimaz","family":"Afrough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farrukh T.","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Larry D.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhuri","family":"Vusirikala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H.","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weina","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michalis","family":"Agathocleous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yazan F.","family":"Madanat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.leukres.2022.107001_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13148-019-0739-5","article-title":"Oral vitamin C supplementation to patients with myeloid cancer on azacitidine treatment: normalization of plasma vitamin C induces epigenetic changes","volume":"11","author":"Gillberg","year":"2019","journal-title":"Clin. Epigenet."},{"issue":"7673","key":"10.1016\/j.leukres.2022.107001_bib2","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/nature23876","article-title":"Ascorbate regulates haematopoietic stem cell function and leukaemogenesis","volume":"549","author":"Agathocleous","year":"2017","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.leukres.2022.107001_bib3","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s42003-020-01391-5","article-title":"Tet2 at the interface between cancer and immunity","volume":"3","author":"Jiang","year":"2020","journal-title":"Commun. Biol."},{"issue":"17","key":"10.1016\/j.leukres.2022.107001_bib4","doi-asserted-by":"crossref","first-page":"4509","DOI":"10.1182\/blood-2010-12-325241","article-title":"Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies","volume":"118","author":"Li","year":"2011","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.leukres.2022.107001_bib5","first-page":"496","article-title":"Nutritional status, dietary intake and serum levels of vitamin C upon diagnosis of cancer in children and adolescents","volume":"27","author":"Lima de Ara\u00fajo","year":"2012","journal-title":"Nutr. Hosp."},{"issue":"1","key":"10.1016\/j.leukres.2022.107001_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1191\/0269216305pm970oa","article-title":"Vitamin C deficiency in cancer patients","volume":"19","author":"Mayland","year":"2005","journal-title":"Palliat. Med."},{"issue":"37","key":"10.1016\/j.leukres.2022.107001_bib7","doi-asserted-by":"crossref","first-page":"10238","DOI":"10.1073\/pnas.1612262113","article-title":"Vitamin C increases viral mimicry induced by 5-aza-2\u2032-deoxycytidine","volume":"113","author":"Liu","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.leukres.2022.107001_bib8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.clnesp.2021.10.014","article-title":"Enriched clonal hematopoiesis in seniors with dietary vitamin C inadequacy","volume":"46","author":"Chen","year":"2021","journal-title":"Clin. Nutr. ESPEN"},{"issue":"6","key":"10.1016\/j.leukres.2022.107001_bib9","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2017.07.032","article-title":"Restoration of TET2 function blocks aberrant self-renewal and leukemia progression","volume":"170","author":"Cimmino","year":"2017","journal-title":"Cell"},{"key":"10.1016\/j.leukres.2022.107001_bib10","first-page":"12","article-title":"Vitamin C deficiency in patients with acute myeloid leukemia. original research","volume":"2022","author":"Ottone","year":"2022","journal-title":"Front. Oncol."},{"issue":"Supplement 1","key":"10.1016\/j.leukres.2022.107001_bib11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1182\/blood-2021-149753","article-title":"Clinical and molecular characteristics associated with vitamin c deficiency in myeloid malignancies; real world data from a prospective cohort","volume":"138","author":"Premnath","year":"2021","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.leukres.2022.107001_bib12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1158\/2643-3230.BCD-21-0143","article-title":"The cell type\u2013specific 5hmc landscape and dynamics of healthy human hematopoiesis and TET2-mutant preleukemia","volume":"3","author":"Nakauchi","year":"2022","journal-title":"Blood Cancer Discov."},{"issue":"1","key":"10.1016\/j.leukres.2022.107001_bib13","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1038\/s41467-018-05085-9","article-title":"Mutant ASXL1 cooperates with BAP1 to promote myeloid leukaemogenesis","volume":"9","author":"Asada","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.leukres.2022.107001_bib14","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1084\/jem.20131141","article-title":"Deletion of Asxl1 results in myelodysplasia and severe developmental defects in vivo","volume":"210","author":"Abdel-Wahab","year":"2013","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.leukres.2022.107001_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.rinim.2016.01.001","article-title":"Ascorbic acid serum levels are reduced in patients with hematological malignancies","volume":"6","author":"Huijskens","year":"2016","journal-title":"Results Immunol."},{"key":"10.1016\/j.leukres.2022.107001_bib16","doi-asserted-by":"crossref","unstructured":"Zhao H., Zhu H., Huang J., et al. The synergy of Vitamin C with decitabine activates TET2 in leukemic cells and significantly improves overall survival in elderly patients with acute myeloid leukemia. Leukemia Research. 2018\/03\/01\/ 2018;66:1\u20137. doi:https:\/\/doi.org\/10.1016\/j.leukres.2017.12.009.","DOI":"10.1016\/j.leukres.2017.12.009"},{"issue":"20","key":"10.1016\/j.leukres.2022.107001_bib17","doi-asserted-by":"crossref","first-page":"32550","DOI":"10.18632\/oncotarget.15925","article-title":"High-dose ascorbate and arsenic trioxide selectively kill acute myeloid leukemia and acute promyelocytic leukemia blasts in vitro","volume":"8","author":"Noguera","year":"2017","journal-title":"Oncotarget"},{"issue":"7461","key":"10.1016\/j.leukres.2022.107001_bib18","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature12362","article-title":"Vitamin\u2009C induces Tet-dependent DNA demethylation and a blastocyst-like state in ES cells","volume":"500","author":"Blaschke","year":"2013","journal-title":"Nature"},{"issue":"24","key":"10.1016\/j.leukres.2022.107001_bib19","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.1182\/bloodadvances.2019000531","article-title":"Vitamin C stabilizes CD8+ iTregs and enhances their therapeutic potential in controlling murine GVHD and leukemia relapse","volume":"3","author":"Iamsawat","year":"2019","journal-title":"Blood Adv."},{"issue":"1","key":"10.1016\/j.leukres.2022.107001_bib20","first-page":"14","article-title":"Emerging epigenetic therapeutics for myeloid leukemia: modulating demethylase activity with ascorbate","volume":"106","author":"Das","year":"2020","journal-title":"Haematologica"}],"container-title":["Leukemia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0145212622003770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T01:03:05Z","timestamp":1758934985000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0145212622003770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":20,"alternative-id":["S0145212622003770"],"URL":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107001","relation":{},"ISSN":["0145-2126"],"issn-type":[{"value":"0145-2126","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and molecular characteristics associated with Vitamin C deficiency in myeloid malignancies; real world data from a prospective cohort","name":"articletitle","label":"Article Title"},{"value":"Leukemia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.leukres.2022.107001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107001"}}